Newly Identified Gene Mutation Can Reduce Fear and Anxiety, Increase Social Interaction

by Adeline Dorcas on  May 3, 2019 at 12:43 PM Genetics & Stem Cells News
RSS Email Print This Page Comment bookmark
Font : A-A+

Newly discovered gene mutation can significantly reduce fear and anxiety, and increase social interaction, reports a new study. The findings of the study are published in the journal Neuropharmacology.
Newly Identified Gene Mutation Can Reduce Fear and Anxiety, Increase Social Interaction
Newly Identified Gene Mutation Can Reduce Fear and Anxiety, Increase Social Interaction

Finnish researchers at the University of Eastern Finland and the University of Oulu have discovered of a new type of gene mutation that reduces fear and anxiety, and increases social interaction.

A team of researchers employed gene manipulation technology to remove the P4h-tm gene from the mouse genome and found an unexpected change in mouse behavior. P4h-tm knockout mice showed striking courage and a lack of learned helplessness compared to congenic wild-type mice with a functional P4h-tm gene.

The research team assessed the mice with a large behavioral test battery that included a novel type of test for the panic reaction. The mice were placed in an air-tight box that was first filled up with regular room air, then with 10 percent carbon dioxide. An elevated concentration of carbon dioxide induces an innate freezing reaction that is thought to resemble the feeling of suffocation in patients suffering from panic attacks. P4h-tm knockout mice displayed substantially less freezing than control mice in response to carbon dioxide exposure.

In tests for social interaction, P4h-tm knockout mice made clearly more contact with another mouse than the controls. In addition, behavioral tests routinely used for screening antianxiety and antidepressant drugs revealed reduced fear, anxiety and learned helplessness in P4h-tm knockout mice. Further, the study found a connection between brain anatomy and the behavioral phenotype: the expression of the P4h-tm gene was especially high in the amygdala that plays a key role in controlling emotional reactions, including fear and anxiety.

The P4h-tm gene accounts for the transcription of the P4H-TM protein. This protein belongs to the family of prolyl-4-hydroxylases that play a pivotal role in the cellular adaptation to a sudden lack of oxygen. However, the P4H-TM protein differs from other prolyl-4-hydroxylases in both its structure and unusual location (endoplasmic reticulum). The physiological role of the P4H-TM protein remains elusive despite years of intensive research, but it is assumed to have other effects on cellular biology besides adaptation to varying oxygen levels.

The research team also tested the inactivation of three other known prolyl-4-hydroxylases in separate mouse lines. These mice did not show abnormal behavior in the above-mentioned tests.

"Our findings are really interesting, but based on a recent international study led by the University of University, we know that the deficiency of the P4H-TM gene results in severe developmental defects in humans," Professor Heikki Tanila from the University of Eastern Finland notes and continues: "However, in light of present knowledge, we cannot tell whether these harmful effects arise from embryonal development or whether they would also appear if the function of the P4H-TM protein was inhibited in the adult age."

"We could best find an answer to this question by using conditional gene inactivation in which the gene could be turned off at any desired age," Dr. Henri Leinonen, the first author of the article, concludes.

"In an ideal experiment, P4h-tm would be turned off only in the amygdala of an adult mouse," Dr. Leinonen adds.

Although the striking effect of P4h-tm gene knockout on the emotional reactions of mice is still far away from the therapeutic application, it can before long lead to the discovery of neurochemical mechanisms that regulate emotions, and can help to develop novel antianxiety and antidepressant drugs. Anxiety disorders and depression are a huge global problem. According to the World Health Organization (WHO), almost 300 million individuals worldwide suffer from anxiety disorders, and over 300 million suffer from depression.

Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions
Advertisement

Recommended Reading

More News on:

DNA Finger Printing Cystic Fibrosis Xenophobia McArdle Disease Weaver Syndrome Inherited Breast Cancer Syndromes Paranoia Von Hippel-Lindau Disease / Rare Genetic Disorder 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive